The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BREAKWATER: Randomized phase 3 study of encorafenib (enco) + cetuximab (cetux) ± chemotherapy for first-line (1L) treatment (tx) of BRAF V600E-mutant (BRAFV600E) metastatic colorectal cancer (mCRC).
 
Scott Kopetz
No Relationships to Disclose
 
Axel Grothey
No Relationships to Disclose
 
Rona Yaeger
No Relationships to Disclose
 
Fortunato Ciardiello
No Relationships to Disclose
 
Jayesh Desai
No Relationships to Disclose
 
Tae Won Kim
No Relationships to Disclose
 
Tim Maughan
No Relationships to Disclose
 
Eric Van Cutsem
No Relationships to Disclose
 
Harpreet Singh Wasan
No Relationships to Disclose
 
Takayuki Yoshino
No Relationships to Disclose
 
Michelle L. Edwards
No Relationships to Disclose
 
Adele Golden
No Relationships to Disclose
 
Ashwin Gollerkeri
No Relationships to Disclose
 
Josep Tabernero
No Relationships to Disclose